MedPath

Comparison of efficacy of oral and vaginal progesterone to prevent preterm birth in pregnant women with short cervix: Randomized controlled trial

Phase 4
Completed
Conditions
Preterm delivery
cervical length
progesterone
Registration Number
TCTR20190324001
Lead Sponsor
none
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
84
Inclusion Criteria

All pregnancy with 20-25 weeks of gestation women who visited ANC clinic at SPS Hospital
A singleton
Cervical length 25 mm or less by transvaginal ultrasound measure

Exclusion Criteria

History of allergy of progesterone
Fetal anomaly
Fetal aneuploidy
Cervical incompetence

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
preterm birth before 34 weeks until the patients delivery medical record of labor at Suspasittiprasong Hospital,preterm birth before 37 weeks until the patients delivery medical record of labor at Suspasittiprasong Hospital
Secondary Outcome Measures
NameTimeMethod
maternal obstatic complication After discharge from Suspasittiprasong Hospital due to delivery medical record at Suspasittiprasong Hospital,neonatal complication After discharge from Suspasittiprasong Hospital due to delivery medical record at Suspasittiprasong Hospital,change in cervical length after progesterone was used 4 weeks after the first measure at date of enrollment measure by transvaginal ultrasound
© Copyright 2025. All Rights Reserved by MedPath